The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury

Free Radical Biology and Medicine

Volumn 27, Issue 1-2, 1999, Pages 160-169

  Ray, Partha S ^a   Maulik, Gautam ^b   Cordis, Gerald A ^a   Bertelli, Alberto A E ^c   Bertelli, Aldo ^c   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Antioxidant; Free radicals; Ischemia; Peroxyl radical; Red wine; Reperfusion; Resveratrol

Indexed keywords

ANTIOXIDANT; BICARBONATE; FREE RADICAL; MALONALDEHYDE; POLYPHENOL; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WINE;

ANIMALS; ANTIOXIDANTS; FREE RADICALS; HEART; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PEROXIDES; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; WINE;

ANIMALIA;

EID: 0032801975     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00063-5     Document Type: Article

References (64)

1. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid history, production, and role in disease prevention . J. Clin. Lab. Anal. 11:1997;287-313.
2. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
3. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279.
4. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273:1998;21875-21882.
5. Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53:1997;1347-1355.
6. Sun A.Y., Chen Y.M., James-Kracke M., Wixom P., Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22:1997;1187-1192.
7. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol. 27:1996;363-366.
8. Das D.K., Engelman R.M., Rousou J.A., Breyer R.H., Otani H., Lemeshow S. Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res. Cardiol. 81:1986;155-166.
9. Tosaki A., Bagchi D., Pali T., Cordis G.A., Das D.K. Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused hearts. A relationship between the genesis of free radicals and reperfusion arrhythmias. Biochem. Pharmacol. 45:1993;961-969.
10. Das D.K., Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol. 233:1994;601-610.
11. Chance B., Sies R., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Res. 59:1979;527-540.
12. Maulik N., Maulik G., Engelman D.T., Cordis G.A., Watanabe M., Das D.K., Engelman R.M. Nitric oxide signaling in ischemic heart. Cardiovasc. Res. 30:1995;593-601.
13. rd, Deaton D.W., Engelman R.M. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann. Thorac. Surg. 59:1995;428-432.
14. Cordis G.A., Maulik N., Das D.K. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J. Mol. Cell. Cardiol. 27:1995;1645-1653.
15. Makrigiorgos G.M., Kassis A.I., Mahmood A., Bump E.A., Savvides P. Novel fluorescein-based flow-cytometric method for detection of lipid peroxidation. Free Radic. Biol. Med. 22:1997;93-100.
16. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
17. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 338:1991;464-468.
18. St. Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1:1979;1017-1020.
19. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., Hunter D.J., Hankinson S.E., Hennekens C.H., Rosner B. Alcohol consumption and mortality among women. N. Engl. J. Med. 332:1995;1245-1250.
20. Klatsky A.L., Armstrong M.A., Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am. J. Cardiol. 66:1990;1237-1242.
21. Goldberg D.M., Hahn S.E., Parkes J.G. Beyond alcohol beverage consumption and cardiovascular mortality . Clin. Chim. Acta. 237:1995;155-187.
22. Kannel W.B., Ellison R.C. Alcohol and coronary heart disease the evidence for a protective effect . Clin. Chim. Acta. 246:1996;59-76.
23. Criqui M.H. Alcohol and coronary heart disease consistent relationship and public health implications . Clin. Chim. Acta. 246:1996;51-57.
24. Seigneur M., Bonnet J., Dorian B., Benchimol D., Drouillet F., Gouverneur G. Effect of the consumption of alcohol, white wine and red wine on platelet function and serum lipids. J. Appl. Cardiol. 5:1990;215-222.
25. Suh I., Shaten B.J., Cutler J.A., Kuller L.H. Alcohol use and mortality from coronary heart disease the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group . Ann. Intern. Med. 116:1992;881-887.
26. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial. N. Engl. J. Med. 329:1993;1829-1834.
27. Gryglewski R.J., Korbut R., Robak J., Swies J. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 36:1987;317-322.
28. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation the Caerphilly Prospective Heart Disease Study . Am. J. Clin. Nutr. 55:1992;1012-1017.
29. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 272:1994;929-933.
30. Veenstra J., Kluft C., Ockhuizen T.H., van der Pol H., Wedel M., Schaafsma G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor. Thromb. Haemost. 63:1990;345-348.
31. Mikhailidis D.P., Jeremy J.Y., Barradas M.A., Green N., Dandona P. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. Br. Med. J. (Clin. Res. Ed.). 287:1983;1495-1498.
32. Galli C., Colli S., Gianfranceshi G., Maderna P., Petroni A., Tremoli E., Marinovich M., Sirtoni C.R. Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation and plasma free fatty acids in normal subjects. Drug-Nutr. Interact. 3:1984;6107.
33. Landolfi R., Steiner M. Ethanol raises prostacyclin in vivo and in vitro. Blood. 64:1984;679-682.
34. Demrow H.S., Slane P.R., Folts J.D. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 91:1995;1182-1188.
35. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
36. Teissedre P.L., Frankel E.N., Waterhouse A.L., Peleg H., German B. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food. Agric. 70:1996;1-7.
37. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F., Castelli F. Flavonoids as antioxidant agents importance of their interaction with biomembranes . Free Radic. Biol. Med. 19:1995;481-486.
38. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61:1997;2103-2110.
39. Criqui M.H., Ringel B.L. Does diet or alcohol explain the French paradox? Lancet. 344:1994;1719-1723.
40. Husain S.R., Cillard J., Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochem. 26:1987;2489-2491.
41. Huguet A.I., Manez S., Alcaraz M.J. Superoxide scavenging properties of flavonoids in a non-enzymic system. Z. Naturforsch. 45:1990;19-24.
42. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37:1988;837-841.
43. Chen Y.T., Zheng R.L., Jia Z.J., Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 9:1990;19-21.
44. -. Free Radic. Biol. Med. 11:1991;1-8.
45. Torel J., Cillard J., Cillard P. Antioxidant activity of flavonoids and reactivity with peroxyl radical. Phytochem. 25:1986;383-385.
46. Beretz A., Anton R., Stoclet J. Inhibition of isolated rat aorta contraction by flavonoids. Possible correlation with cyclic AMP phosphodiesterase inhibition. Planta. Med. 39:1980;236-237.
47. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 24:1993;857-862.
48. Fitzpatrick D.F., Hirschfield S.L., Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 265:1993;H774-H778.
49. Cishek M.B., Galloway M.T., Karim M., German J.B., Kappagoda C.T. Effect of red wine on endothelium-dependent relaxation in rabbits. Clin. Sci. (Colch.). 93:1997;507-511.
50. Siemann E.H., Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43:1992;49-52.
51. Lamuela-Raventos R.M., Waterhouse A.L. Occurrence of resveratrol in selected California wines by a new HPLC method. J Agric. Food Chem. 41:1993;521-522.
52. Jeandet P., Bessis R., Maume B.F., Sbaghi M. Analysis of resveratrol in burgundy wines. J. Wine Res. 4:1993;79-85.
53. Mattivi F. Solid phase extraction of trans-resveratrol from wines for HPLC analysis. Z. Lebensm. Unters. Forsch. 196:1993;522-525.
54. Lamuela-Raventos R.M., Romero-Perez A.I., Waterhouse A.L., Carmen de la Torre-Bonnat M. Direct HPLC analysis of cis- and trans-resveratrol and peceid isomers in Spanish red vitis vinifera wines. J. Agric. Food Chem. 43:1995;281-283.
55. Belguendouz L., Fremont L., Gozzelino M.T. Interaction of transresveratrol with plasma lipoproteins. Biochem. Pharmacol. 55:1998;811-816.
56. Bertelli A.A.E., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M., Bertelli A. Anti-platelet activity of synthetic and natural resveratrol in red wine. Int. J. Tiss. Reac. XVII:1995;1-3.
57. Bertelli A.A.E., Giovannini L., Giannesi D., Panichi V., Bertelli A. Anti-aggregating activity of trans- and cis-resveratrol. Fibrinolys. 10:1996;35-36.
58. Bertelli A.A.E., Giovannini L., Stradi R., Urien S., Tillement J.P., Bertelli A. Kinetics of trans- and cis-resveratrol (3,4′,5-trihydoxystilbene) after red wine oral administration in rats. Int. J. Clin. Pharm. Res. XVI:1996;77-81.
59. Bertelli A.A.E., Giovannini L., Stradi R., Bertelli A., Tillement J.P. Plasma, tissue and urine levels of trans- and cis-resveratrol (3,4′,5-trihydoxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tiss. Reac. XVIII:1996;67-71.
60. Bertelli A.A.E., Giovannini L., Stradi R., Urien S., Tillement J.P., Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp. Clin. Res. 24:1998;51-55.
61. Bertelli A., Bertelli A.A.E., Gozzini A., Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24:1998;133-138.
62. Nonomura S., Kanagawa H., Makimoto A. Chemical constituents of polygonaceous plants. Studies on the components of Ko-jo-kon (Polygonum cuspidatum SIEB et ZUCC). Yakugaku Zasshi. 83:1963;988-990.
63. Kubo M., Kimura Y., Shin H., Haneda T., Tani T., Namba K. Studies on the antifungal substance of crude drug (II). On the roots of Polygonum cuspidatum Sieb. Et Zucc (Polygonaceae). Shoyakugaku Zasshi. 35:1981;58-61.
64. Draczynska-Lusiak B., Chen Y.M., Sun A.Y. Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells. Neuroreport. 9:1998;527-532.